News

Also IntelyCare makes slew of new hires and PixCell Medical adds to board chair. 

Castor, a cloud-based clinical data platform designed to automate the research process, announced recently it closed a $12 million Series A funding round.

The data-driven blood glucose monitor system-maker will use the money to push into new areas of disease management, such as cardiology, oncology and women's health.

The app will facilitate the exchange of crucial information such as X-rays and guidance to ensure orthopaedic injuries get treatment in an appropriate time frame.

The device was originally developed at MIT with Harvard Medical School.

During a HIMSS20 Digital session, Trapollo CEO Mike Braham described some of the ways that remote care apps can support patient needs.  

Digital Diagnostics, formerly IDx, is looking to expand into the skin health space with this new purchase. 

Also: Klara closes $15 million for digital patient engagement; Trellus Health collects $5 million seed funding and announces exclusive commercialization deal.

Artificial intelligence-enabled in vitro diagnostics company Renalytix AI announced today a research partnership with AstraZeneca to develop and launch medical strategies for cardiovascular, renal and metabolic diseases.

After her daughter's PFIC diagnosis, Claire Brinkley searched for a way to connect with other parents with similar experiences and questions.